Monday, January 20, 2014

Pharmaceutical Industry Funding of Anti-homeopathy Skeptic Groups Uncovered

Pharmaceutical Industry Funding of Anti-homeopathy Skeptic Groups Uncovered

Sense about Science, a well funded anti-homeopathy skeptic organization in the United Kingdom complained about a consumer’s group’s assertion that they represent and are funded by the pharmaceutical industry.  After further investigation, even more funding than previously revealed has been uncovered. “In investigating their complaints we looked more closely at the sources of funding of Sense About Science, and have found that our original figures for the charity’s support by the pharmaceutical industry were too conservative.”
The consumer group, H:MC21 also wrote in response to Sense about Science complaining:
You quote us as saying that Sense About Science “received over 35% of its donation funding from the pharmaceutical industry between 2004 and 2009”, but then refer only to funding “from pharmaceutical companies”. As a result of the investigation following your email, we have found that our original claim about Sense About Science’s funding was too conservative. In fact Sense About Science appears to have received an average of 42.3% of its total income between 2004 and 2010 from pharmaceutical companies or organisations clearly linked to the pharmaceutical industry. In 2006, the year [the anti-homeopathy] ‘Sense About Homeopathy’ was published, there was a huge leap in such funding, from £37,300 (36.9% of total income) to £102,165 (51.2% of total income). Full details are included in Appendix 1.
The Canadian skeptic organization called Centre for Inquiry, which is another anti-homeopathy skeptic group, is almost entirely funded by a director of a pharmaceutical company. They have initiated a law suit against a homeopathic manufacturer and retail pharmacy selling homeopathic remedies.
Both groups are attempting to stop consumers’ choice of alternative health modalities and stop the sale of homeopathic remedies.

No comments:

Post a Comment